← Leaderboards
David F Wiemer
Washington University
$887,365
Attributed
$2,600,654
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $515.1K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,600,654 · 3
By mechanism
R01$2,599,267 · 2
P41$1,387 · 1
Top collaborators
- Sarah A Holstein6 shared
- Aaron M. Mohs5 shared
Most similar at Washington University
Same institution · by research overlap
- Jean-Luc G Montchamp$839,744
- David G Denardo$14,438,310
- Mark A Watson$16,564,971
- Rebecca L Aft$2,199,928
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignProteinsEnzymesMetabolicNovel TherapeuticsPlasma CellsIn VitroIsoprenoidMalignant NeoplasmsMediatingMultiple MyelomaNovel Therapeutic InterventionPathway InteractionsDrug CombinationsLeadGeranylgeranylationApoptosisCellsMorbidity - Disease RateMalignant - DescriptorBone MarrowCell DeathEnzyme InhibitionProtein Secretion
Grant awards (7)
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$503,088
R01 · FY2025 · CA
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$477,934
R01 · FY2024 · CA
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$493,027
R01 · FY2023 · CA
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$492,732
R01 · FY2022 · CA
Geranylgeranyl diphosphate synthase inhibitor therapy for multiple myeloma$515,150
R01 · FY2021 · CA
Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma$117,336
R01 · FY2016 · CA
STRATEGIES FOR ORGANIC SYNTHESIS BASED ON ORGANOPHOSPHORUS COMPOUNDS$1,387
P41 · FY2007 · RR · contact PI